Clinical Trials in Yamaguchi, Japan
12 recruiting
Showing 1–12 of 12 trials
Recruiting
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Factor Xa InhibitorLife Threatening Bleeding
AstraZeneca300 enrolled66 locationsNCT05454787
Recruiting
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Astellas Pharma Inc3,000 enrolled47 locationsNCT03971253
Recruiting
Phase 2
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Chronic MigraineEpisodic Migraine
Ipsen641 enrolled166 locationsNCT06625060
Recruiting
Phase 3
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Non-small Cell Lung Cancer
Summit Therapeutics1,600 enrolled253 locationsNCT05899608
Recruiting
Phase 1Phase 2
PrProfile: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION717
Prion Disease
Ionis Pharmaceuticals, Inc.76 enrolled13 locationsNCT06153966
Recruiting
Phase 3
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Eli Lilly and Company510 enrolled194 locationsNCT06338995
Recruiting
Phase 2Phase 3
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Corxel Pharmaceuticals740 enrolled83 locationsNCT06990867
Recruiting
Phase 3
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
Heart Failure
Novo Nordisk A/S5,600 enrolled1117 locationsNCT05636176
Recruiting
An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan
Crohn's Disease
AbbVie240 enrolled104 locationsNCT06023030
Recruiting
Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
Refractory Chronic CoughCough
Bellus Health Inc. - a GSK company975 enrolled242 locationsNCT05600777
Recruiting
Phase 3
ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Epilepsy, Generalized
Ono Pharmaceutical Co., Ltd.15 enrolled25 locationsNCT06579573
Recruiting
Phase 3
Phase III Trial of Stage I Ovarian Cancer After Surgery
Epithelial Ovarian Cancer
Japanese Gynecologic Oncology Group360 enrolled103 locationsNCT04063527